Our Projects
From evidence to translation and implementation
Stewarding scientific endeavours from inception to real-world impact
We aim to strengthen the evidence around the nutrition-microbiome-immune system axis in cancer, and to translate such evidence into actionable novel approaches for personalised cancer diagnosis and treatment. To do so, we support mechanistic, observational and interventional studies across the full spectrum of scientific and clinical research. Furthermore, we enable translational projects and early stage start-ups that may act as accelerators to our mission.
Seerave closely stewards its projects with the aim to foster cooperation across both institutional and national boundaries. We act as a catalyst to pool experience and knowledge and ensure that novel scientific concepts can move quickly from inception to real-world impact.
Weizmann Institute of Science
Metabolomics platform to accelerate the identification of novel drivers of disease
- Eran Segal
- Adina Weinberger
Institut Gustave Roussy (IGR)
Ketogenesis to enhance immunotherapy in advanced renal cell cancer
- Laurence Zitvogel
- Marine Fidelle
- Lisa Derosa
Weizmann Institute of Science
Personalised nutritional intervention to enhance the efficacy of breast cancer therapy
- Eran Segal
- Michal Rein
- Thomas Vogl
- Iris Kalka
Closed Project Helbling
King's College London (KCL)
Predicting response to immunotherapy based on microbiome and metabolites
- Tim Spector
- Veronique Bataille
- Karla Lee
- Paul Nathan
Florey Biosciences
An engineered probiotic to manage the impacts of antibiotics
- Andrés Cubillos-Ruiz
- Raphaël Gayet
MD Anderson Cancer Center (MDACC)
Controlled high fiber diet interventions in melanoma patients
- Jennifer McQuade
- Yan Jiang (Janie)
The Microbiome Virtual International Forum
Recurring bite-sized alternative to multi-day microbiome conference
- Levi Waldron
- Nicola Segata
Rutgers University
Restoration of Antibiotics Effects on the Infant Microbiota by Autologous Fecal Transplant
- Gloria Dominguez-Bello
- Anna Dulencin
Gustave Roussy
PREVALUNG: Personalized lung cancer risk assessment leading to stratified Interception
- Laurence Zitvogel
- Marine Fidelle
- Carolina Alves Costa Silva
University of California San Diego (UCSD)
- Jack Gilbert
- Joshua Tran
University Medical Center Groningen (UMCG)
- Rinse Weersma
- Laura Bolte
CR CHUM
Impact of castalagin prebiotic on the gut microbiota and immune response to anti-PD-1 therapy
- Bertrand Routy
- Meriem Messaoudene
Periodic Table of Food
A reference database of the composition and the function of food we eat
- Roy Steiner
- John de la Parra
Xsensio
Lab-on-Skin™ platform for next-generation wearables
- Esmeralda Megally
- Adrian Ionescu
- Ron Gill
- Hervé Elettro
Arma Bioscience
At home personalised health monitoring at the molecular level
- Shana Kelley
- Surath Gomis
- Hanie Yousefi
BiomeSense
Standardised microbiome collection and analysis for clinical trials
- Kevin Hoenaker
- Jack Gilbert
Abselion
Biosensors for rapid detection of biological substances in labs
- Dr. Ruizhi Wang
- Christoph v. Bieberstein
The Deep Immunity Project
Geneva University Hospital (HUG)
High-resolution investigation of personalised post-prandial inflammation biomarkers
- Thomas Gurry
Institut Gustave Roussy (IGR)
Characterising and modulating cancer-associated ileopathy
- Laurence Zitvogel
The Microbiota Vault
Preserving the diversity of human-associated microbiota
- Martin Blaser
- Maria Gloria Dominguez-Bello
- Dominik Steiger
The Invisible Extinction
Documentary movie about the microbiome in health and disease
- Steven Lawarence
- Sarah Schenck
Technion
Impact of microbiome-derived metabolites on immune cells
- Naama Geva-Zatorsky
- Tal-avi Gefen
- Noa Mandelbaum
- Roni Keshet
- Rachel Herren
University Medical Center Groningen (UMCG)
Predicting response to immunotherapy based on diet and microbiome
- Rinse Weersma
- Geke Hospers
- Laura Bolte
- Johannes Björk
Closed Project Weizmann Institute of Science
Novel diagnostics for the detection of coronavirus antibodies
- Eran Segal
- Thomas Vogl
Institut Gustave Roussy (IGR)
The role of ACBP/DBI, a novel metabolic checkpoint protein, in the cancer-immune dialogue
- Guido Kroemer
- Isabelle Martins
- Léa Montegut
Swiss Federal Institute of Technology (EPFL)
AI-assisted food tracking to revolutionize nutritional research
Micronoma
Early-stage cancer detection using liquid biopsy of microbial DNA
- Sandrine Miller-Montgomery
- Greg Sepich-Poore
- Rob Knight
- Eddie Adams
Closed Project University Psychiatric Clinics Basel (UPK)
Fecal microbiome transfer in patients with severe depression
- André Schmidt
- Laura Mählmann
Closed Project Institut Gustave Roussy (IGR)
Impact of nutrients on cancer immunotherapy
- Laurence Zitvogel
- Guido Kroemer
- Jonathan Pol
- Maryam Tidjani-Alou
- Gladys Ferrere
Seerave Foundation
